The AONYS® platform is able to formulate water soluble active ingredients of various sizes such as metal ions, chelating molecules, peptides and oligonucleotides. In addition, stable ultra-small nanoparticles may be manufactured in situ, opening up new opportunities in the field of nano-medicine.
Therapeutic areas under development:
- Neurodegenerative diseases with lithium ion
- Alzheimer’s disease
- Huntington’s disease with siRNAs targeting the mutant Huntingtin
- Acute Respiratory Distress Syndrome / COVID-19 with Manganese ion
- COVID-19 with an siRNA targeting the virus genome
- Decorporation of cesium with chelating molecules
- Radioprotection and radiomitigation after nuclear irradiation
Research therapeutic areas:
- Customized treatment of resistant cancers with siRNAs and peptides
- Oncology collaboration with the company Transgene